506 related articles for article (PubMed ID: 27671847)
1. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
Davies LC; Heldring N; Kadri N; Le Blanc K
Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
[TBL] [Abstract][Full Text] [Related]
2. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
3. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
4. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
[TBL] [Abstract][Full Text] [Related]
5. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
Strauch V; Saul D; Berisha M; Mackensen A; Mougiakakos D; Jitschin R
Stem Cells; 2020 Aug; 38(8):986-993. PubMed ID: 32346937
[TBL] [Abstract][Full Text] [Related]
7. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions.
Yan Z; Zhuansun Y; Liu G; Chen R; Li J; Ran P
Immunol Lett; 2014 Nov; 162(1 Pt A):248-55. PubMed ID: 25281059
[TBL] [Abstract][Full Text] [Related]
9. Poly I:C primes the suppressive function of human palatine tonsil-derived MSCs against Th17 differentiation by increasing PD-L1 expression.
Cho KA; Park M; Kim YH; Ryu KH; Woo SY
Immunobiology; 2017 Feb; 222(2):394-398. PubMed ID: 27594385
[TBL] [Abstract][Full Text] [Related]
10. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
11. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells.
Moravej A; Karimi MH; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Khosravi M; Kalani M; Gharesi-Fard B
Immunol Invest; 2017 Jan; 46(1):80-96. PubMed ID: 27736253
[TBL] [Abstract][Full Text] [Related]
14. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
[TBL] [Abstract][Full Text] [Related]
15. Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease
Hackel A; Vollmer S; Bruderek K; Lang S; Brandau S
Front Immunol; 2023; 14():1078551. PubMed ID: 36875112
[TBL] [Abstract][Full Text] [Related]
16. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
Front Immunol; 2021; 12():686356. PubMed ID: 34484183
[TBL] [Abstract][Full Text] [Related]
17. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells.
Yang M; Liu P; Wang K; Glorieux C; Hu Y; Wen S; Jiang W; Huang P
Mol Oncol; 2017 Apr; 11(4):358-372. PubMed ID: 28218497
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells.
Grinnemo KH; Löfling M; Nathanson L; Baumgartner R; Ketelhuth DFJ; Beljanski V; Davies LC; Österholm C
Stem Cell Res Ther; 2019 Dec; 10(1):371. PubMed ID: 31801632
[TBL] [Abstract][Full Text] [Related]
20. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
